RESOURCE LIBRARY

PHYSICIAN RESOURCES

Tyson S, et al, JCRS Journal. 2019;45(2): 204-212

DOWNLOAD

Tyson S, et al, JCRS Journal. 2019;45(2):204-212 [erratum in: 2019;45(6):895].

VIEW

Walters T, et al, J Clin Exp Ophthalmol. 2016;7(4):1-11.

DOWNLOAD

CODING AND REIMBURSEMENT INFORMATION

DEXTENZA Coding Overview

DOWNLOAD

DEXTENZA Patient Access and Services Overview

DOWNLOAD

PRODUCT REPLACEMENT INFORMATION AND FORMS

DEXTENZA Replacement Product Card

DOWNLOAD

DEXTENZA Product Replacement Attestation Form 1-5 Product Units

DOWNLOAD

DEXTENZA Product Replacement Attestation Form 6+ Product Units

DOWNLOAD

DEXTENZA360.COM PORTAL INFORMATION AND FORMS

DEXTENZA360 Portal User Guide

DOWNLOAD

DEXTENZA Enrollment Form and Benefit Verification Summary Guide

DOWNLOAD

DEXTENZA360 Patient Enrollment Form

DOWNLOAD

PATIENT ASSISTANCE PROGRAMS INFORMATION AND FORM

DEXTENZA Patient Assistance Program Patient Instructions English

DOWNLOAD

DEXTENZA Patient Assistance Program Patient Instructions Spanish

DOWNLOAD

DEXTENZA Patient Assistance Program Application Form

DOWNLOAD

DEXTENZA PURCHASING OPTIONS

DEXTENZA Ordering Guide

DOWNLOAD

TECHNIQUE VIDEOS

 
John Berdahl, MD*

Vance Thompson Vision

Sioux Falls, SD

 
Sydney L. Tyson, MPH*

Eye Associates and SurgiCenter of Vineland

Vineland, NJ

 
Dee Stephenson, MD*

Stephenson Eye Associates

Venice, FL

 
John Hovanesian, MD*

Harvard Eye Associates

Orange County, CA

 
Eric D. Donnenfeld, MD*

OCLI / Ophthalmic Consultants of Long Island

Long Island, NY

 
Cynthia Matossian, MD*

Matossian Eye Associates

Doylestown, PA

SURGEON TESTIMONIALS

 
Shamik Bafna, MD*

Cleveland Eye Clinic

Cleveland, OH

 
Mitchell A. Jackson, MD*

Jacksoneye

Lake Villa, IL

 
Paul Singh, MD*

The Eye Centers of Racine & Kenosha

Racine, WI & Kenosha, WI

 
Sumitra Khandelwal, MD*

Baylor College of Medicine

Houston, TX

 
Dee Stephenson, MD*

Stephenson Eye Associates

Venice, FL

 
Zaina Al-Mohtsaeb, MD*

Alkek Eye Center

Houston, TX

 
Tal Raviv, MD*

Eye Center of New York

New York, NY

*Paid Consultant providing service to Ocular Therapeutix, inc.

  open
  close
IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

DEXTENZA is contraindicated in patients with active corneal, conjunctival or canalicular infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella; mycobacterial infections; fungal diseases of the eye, and dacryocystitis.

WARNINGS AND PRECAUTIONS

Intraocular Pressure Increase – Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be monitored during treatment.

Bacterial Infections – Corticosteroids may suppress the host response and thus increase the hazard for secondary ocular infections. In acute purulent conditions, steroids may mask infection and enhance existing infection.

Viral Infections – Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex).

Fungal Infections – Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal culture should be taken when appropriate.

Delayed Healing – Use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.

Other Potential Corticosteroid Complications – The initial prescription and renewal of medication order of DEXTENZA should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy, and, where appropriate, fluorescein staining. If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated.

ADVERSE REACTIONS

Ocular Inflammation and Pain Following Ophthalmic Surgery
The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%), intraocular pressure increased (6%), visual acuity reduced (2%), cystoid macular edema (1%), corneal edema (1%), eye pain (1%), and conjunctival hyperemia (1%). The most common non-ocular adverse reaction was headache (1%).

Itching Associated with Allergic Conjunctivitis
The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: intraocular pressure increased (3%), lacrimation increased (1%), eye discharge (1%), and visual acuity reduced (1%). The most common non-ocular adverse reaction was headache (1%).

INDICATIONS

DEXTENZA is a corticosteroid indicated for:

  • The treatment of ocular inflammation and pain following ophthalmic surgery.
  • The treatment of ocular itching associated with allergic conjunctivitis.